-
{{ listItem.name }}快速筛选药品，用摩熵药筛
微信扫一扫-立即使用
-
产品立项评估及管线规划
-
数据定制服务
-
产业/行业调研
-
市场洞察咨询服务
-
报告大厅
已收录 68518 份 -
摩熵说直播
最新改良型新药及创新药立项开发
- GLP-1
ChiCTR-OIN-12002703
结束
/
/
/
2012-07-30
/
/
Refractive Error
Comparative Evaluation of Side Cut Angles during Femtosecond LASIK
Comparative Evaluation of Side Cut Angles during Femtosecond LASIK
Comparative Evaluation of Side Cut Angles during Femtosecond LASIK
非随机对照试验
Ⅰ期
Non-randomized
Double-blind
NA
/
0;50
/
1990-01-01
1990-01-01
/
1. Patients intending to receive bilateral LASIK; 2. Age of >21 years; 3. Myopic refractive error; 4. Informed consent.；
登录查看1. Patients who are found to be unsuitable for inverse cut angle 2. Patients contraindicated for refractive surgery; 3. Pre-existing corneal haze; 4. Patients unable to complete the follow-up.；
登录查看The Chinese University of Hong Kong
/
The Chinese University of Hong Kong的其他临床试验
- Sports Programmes for Persons with Disabilities or Special Needs - Adapted sports programme for students with disabilities or special needs for three years
- Taurine Or Placebo for Healthcare Workers: the TOP Healthcare workers' Bayesian Optimized Phase II randomised-controlled trial
- Promoting physical activity among primary school children and their families in Hong Kong: A community-based healthy lifestyle program ("F.I.T. Family")
- Exploring the augmentative effects and mechanisms of integrating computerized cognitive training with transcranial magnetic stimulation in late-life depression: a proof-of-concept randomized controlled trial
- A Case-management, Family-centred and Multicomponent Programme to Support Family Caregivers in Caregiving and Mental Health Crisis - Evaluation Study
- AI Versus Human-Generated Multiple-Choice Questions for Medical Education: A Cohort Study in a High-Stakes Examination
- A group-based compassionate mind training on depression in Hong Kong: a pilot randomized control trial
- Resistome of gut microbiota and modulation in healthy Hong Kong population
- Running for Development for ADHD youth
- Implementation of an integrated Self-Care Health Service Ecosystem
- A Randomized Controlled Trial of Physical Activity Intervention on Neurocognitive Performance, Mental Health, and Behavioural Outcomes of Children with Attention Deficit Hyperactivity Disorder
- The effect of a theory-based educational program on nutritional knowledge, health-related behavior, and health outcomes in individuals with obesity in Hong Kong community settings
- 自閉症兒童同理心幹預
- Readiness for E-Mental Health- Awareness, Acceptance, and Preference Towards Technology-Mediated Mental Health Treatment among Individuals with Elevated Depressive Symptoms in Hongkong: A Survey Study and Effect of Web-Based Decision Aids on Preferences Shift
- 一項利用機器學習的自動視網膜圖像分析 (ARIA) 和營養干預預防阿爾茨海默病和認知障礙症的試點研究
- 機器學習方法進行視網膜圖像分析的自閉症譜系障礙(ASD)和幼兒總體發育延遲(GDD)的分類
- Autonomous social robots detect and intervene autism
- Age with good mood: a volunteer network based medical-social collaborative programme for supporting underprivileged older adults: a two-arm, assessor blind randomized wait-list controlled trial for recipients
- Age with good mood: a volunteer network based medical-social collaborative programme for supporting underprivileged older adults: a single-/within-group study design for volunteers
- Please fill in the data management platform. Impact of intravenous iron therapy on outcomes and exercise performance in cardiac surgical patients
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong的其他临床试验
- 利用下一代蛋白質組學技術鑑定淚膜中青光眼的生物標誌物
- 比較絲裂黴素C合併支架植入術與單純黏膜瓣保留鼻內鏡下淚囊鼻腔吻合術對原發性鼻淚管阻塞 的手術療效
- 低濃度阿托品眼藥水在近視發病預防之研究
- 比效玻璃體注射類固醇(triamcinolone acetonide)及抗血管內皮生長因子藥物(ranibizumab)聯合療法和單一注射抗血管內皮生長因子藥物(ranibizumab)治療新生血管老年性黃斑病變之療效及安全性的前膽性研究
- 對原發性開角型青光眼、原發性閉角型青光眼或高眼壓病人施用0.0015% Tafluprost（他氟前列素）滴眼液後的24小時眼球內壓概況的研究
- 比較淚囊鼻腔造口術作為初期或早期治療急性淚囊炎之效果
- 比較雙眼對側於不同准分子激光膜原位磨鑲手術角膜瓣厚度的前瞻性研究
- Comparative Evaluation of Side Cut Angles during Femtosecond LASIK
- The Safety and Efficacy of Combined Subtenon Triamcinolone and Grid Laser Photocoagulation as Primary Treatment for Diabetic Macular Edema - A Pilot Study
最新临床资讯
-
重磅！全球首个偏向型GLP-1减重药中国III期临床数据荣登《柳叶刀》子刊
-
新药每周一次，93%中国患者成功减重，还降三高、尿酸和脂肪肝！纪立农教授领衔研究登《柳叶刀》子刊
-
diabetes 埃诺格鲁肽 SLIMMER
医药笔记2025-06-22
-
遗传性血管性水肿 III期 BD项目
美柏资本2025-06-22
-
ADA GIPR PCSK9
信达生物2025-06-22
-
diabetes 埃诺格鲁肽 内分泌学
先为达生物2025-06-22
-
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
-
EGFR 结直肠癌 JMT101
石药集团2025-06-21
-
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
-
肥胖 Wegovy
一度医药2025-06-21
18983288589（微信同号）
18983288589（微信同号）
18908392210（微信同号）
18980413049
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: tyc7111cc太阳成集团 tyc7111cc太阳成集团企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网